NRIX Nurix Therapeutics, Inc.
Nasdaq · SEC CIK 1549595 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $4.53M 32 sales by 3 insiders
- Filings on record
- 197 since 2021-07-02, latest 2026-09-02 19:42
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Ring Christine | CLO | — | $3.26M |
| van Houte Hans | CFO | — | $635.3K |
| Hansen Gwenn | CSO | — | $630.9K |
Transactions 233
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-26 | 2024-08-26 | NRIX | Ring Christine | CLO | S - Sale+OE | $25.01 | -9,870 | 24.6K | -29% | -$246.8K |
| DM | 2024-08-26 | 2024-08-26 | NRIX | Ring Christine | CLO | M - OptEx | $6.08 | +9,870 | 29.1K | +51% | +$60.0K |
| 2024-08-26 | 2024-08-26 | NRIX | van Houte Hans | CFO | S - Sale | $25.22 | -20.0K | 31.0K | -39% | -$504.4K | |
| M | 2024-08-01 | 2024-08-01 | NRIX | van Houte Hans | CFO | S - Sale | $21.45 | -3,477 | 51.0K | -6% | -$74.6K |
| DM | 2024-08-01 | 2024-08-01 | NRIX | Ring Christine | CLO | S - Sale+OE | $21.43 | -5,760 | 24.6K | -19% | -$123.4K |
| D | 2024-08-01 | 2024-08-01 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 30.4K | +23% | +$10.7K |
| D | 2024-07-30 | 2024-07-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $20.67 | -3,408 | 45.1K | -7% | -$70.4K |
| DM | 2024-07-30 | 2024-07-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +8,957 | 42.8K | +26% | $0 |
| D | 2024-07-30 | 2024-07-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $20.67 | -2,920 | 24.6K | -11% | -$60.4K |
| DM | 2024-07-30 | 2024-07-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +7,674 | 21.8K | +54% | $0 |
| DM | 2024-07-30 | 2024-07-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +8,636 | 53.2K | +19% | $0 |
| D | 2024-07-30 | 2024-07-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $20.67 | -2,490 | 54.5K | -4% | -$51.5K |
| 2024-07-18 | 2024-07-17 | NRIX | Kunkel Lori Anne | Dir | G - Gift | $0.00 | -54.0K | 0 | -100% | $0 | |
| D | 2024-07-01 | 2024-07-01 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +5,760 | 25.6K | +29% | +$10.7K |
| DM | 2024-07-01 | 2024-07-01 | NRIX | Ring Christine | CLO | S - Sale+OE | $20.80 | -5,760 | 20.6K | -22% | -$119.8K |
| 2024-06-20 | 2024-06-20 | NRIX | van Houte Hans | CFO | S - Sale | $20.01 | -20.0K | 48.3K | -29% | -$400.2K | |
| D | 2024-06-13 | 2024-06-13 | NRIX | Ring Christine | CLO | S - Sale+OE | $17.02 | -1,864 | 19.8K | -9% | -$31.7K |
| D | 2024-06-13 | 2024-06-13 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +1,864 | 21.7K | +9% | +$3,467 |
| D | 2024-06-12 | 2024-06-12 | NRIX | Ring Christine | CLO | S - Sale+OE | $17.01 | -1,900 | 19.8K | -9% | -$32.3K |
| D | 2024-06-12 | 2024-06-12 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +1,900 | 21.7K | +10% | +$3,534 |
| D | 2024-06-05 | 2024-06-05 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +400 | 20.2K | +2% | +$744 |
| D | 2024-06-05 | 2024-06-05 | NRIX | Ring Christine | CLO | S - Sale+OE | $17.00 | -400 | 19.8K | -2% | -$6,800 |
| D | 2024-06-03 | 2024-06-03 | NRIX | Ring Christine | CLO | M - OptEx | $1.86 | +1,596 | 21.4K | +8% | +$2,969 |
| D | 2024-06-03 | 2024-06-03 | NRIX | Ring Christine | CLO | S - Sale+OE | $17.01 | -1,596 | 19.8K | -7% | -$27.1K |
| 2024-05-02 | 2024-05-02 | NRIX | van Houte Hans | CFO | S - Sale | $12.83 | -3,499 | 68.3K | -5% | -$44.9K | |
| DM | 2024-04-30 | 2024-04-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +4,886 | 71.2K | +7% | $0 |
| D | 2024-04-30 | 2024-04-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $12.04 | -1,387 | 71.8K | -2% | -$16.7K |
| DM | 2024-04-30 | 2024-04-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +3,924 | 19.4K | +25% | $0 |
| D | 2024-04-30 | 2024-04-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $12.04 | -1,513 | 19.8K | -7% | -$18.2K |
| DM | 2024-04-30 | 2024-04-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +5,206 | 41.6K | +14% | $0 |
| D | 2024-04-30 | 2024-04-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $12.04 | -2,007 | 39.6K | -5% | -$24.2K |
| 2024-02-16 | 2024-02-16 | NRIX | van Houte Hans | CFO | S - Sale | $10.02 | -6,812 | 68.3K | -9% | -$68.3K | |
| DM | 2024-01-30 | 2024-01-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +4,886 | 76.8K | +7% | $0 |
| D | 2024-01-30 | 2024-01-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $7.99 | -1,671 | 75.1K | -2% | -$13.4K |
| D | 2024-01-30 | 2024-01-30 | NRIX | Ring Christine | CLO | S - Sale+OE | $7.99 | -1,760 | 17.4K | -9% | -$14.1K |
| DM | 2024-01-30 | 2024-01-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +3,924 | 17.2K | +30% | $0 |
| DM | 2024-01-30 | 2024-01-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +5,207 | 36.7K | +17% | $0 |
| D | 2024-01-30 | 2024-01-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $7.99 | -2,334 | 36.4K | -6% | -$18.6K |
| 2023-12-21 | 2023-12-20 | NRIX | van Houte Hans | CFO | S - Sale | $10.00 | -3,541 | 71.9K | -5% | -$35.4K | |
| 2023-12-20 | 2023-12-19 | NRIX | van Houte Hans | CFO | S - Sale | $10.00 | -10.9K | 75.5K | -13% | -$109.1K | |
| D | 2023-11-01 | 2023-10-31 | NRIX | Ring Christine | CLO | S - Sale+OE | $5.20 | -1,232 | 15.3K | -7% | -$6,406 |
| DM | 2023-11-01 | 2023-10-30 | NRIX | Ring Christine | CLO | M - OptEx | $0.00 | +3,924 | 16.5K | +31% | $0 |
| D | 2023-11-01 | 2023-10-31 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $5.20 | -1,633 | 33.5K | -5% | -$8,492 |
| DM | 2023-11-01 | 2023-10-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +5,207 | 33.2K | +19% | $0 |
| D | 2023-11-01 | 2023-10-31 | NRIX | van Houte Hans | CFO | S - Sale+OE | $5.20 | -1,080 | 86.4K | -1% | -$5,616 |
| DM | 2023-11-01 | 2023-10-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +4,886 | 85.5K | +6% | $0 |
| DM | 2023-08-01 | 2023-07-30 | NRIX | Ring Christine | GC | M - OptEx | $0.00 | +3,924 | 12.0K | +49% | $0 |
| D | 2023-08-01 | 2023-07-31 | NRIX | Ring Christine | GC | S - Sale+OE | $9.65 | -1,420 | 12.5K | -10% | -$13.7K |
| DM | 2023-08-01 | 2023-07-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +5,207 | 31.8K | +20% | $0 |
| D | 2023-08-01 | 2023-07-31 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $9.65 | -1,884 | 30.0K | -6% | -$18.2K |
| DM | 2023-08-01 | 2023-07-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +4,886 | 81.8K | +6% | $0 |
| D | 2023-08-01 | 2023-07-31 | NRIX | van Houte Hans | CFO | S - Sale+OE | $9.65 | -1,245 | 82.6K | -1% | -$12.0K |
| D | 2023-05-02 | 2023-04-30 | NRIX | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 6,455 | +18% | $0 |
| D | 2023-05-02 | 2023-05-01 | NRIX | Wolff Stefani | EVP, COO | S - Sale+OE | $9.88 | -342 | 6,113 | -5% | -$3,379 |
| D | 2023-05-02 | 2023-05-01 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $9.88 | -1,136 | 26.6K | -4% | -$11.2K |
| D | 2023-05-02 | 2023-04-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +3,206 | 27.8K | +13% | $0 |
| D | 2023-05-02 | 2023-04-30 | NRIX | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 10.7K | +22% | $0 |
| D | 2023-05-02 | 2023-05-01 | NRIX | Ring Christine | GC | S - Sale+OE | $9.88 | -682 | 10.0K | -6% | -$6,738 |
| D | 2023-05-02 | 2023-04-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +2,886 | 79.7K | +4% | $0 |
| D | 2023-05-02 | 2023-05-01 | NRIX | van Houte Hans | CFO | S - Sale+OE | $9.88 | -721 | 78.9K | -0.9% | -$7,123 |
| D | 2023-02-01 | 2023-01-30 | NRIX | van Houte Hans | CFO | S - Sale+OE | $11.78 | -924 | 76.8K | -1% | -$10.9K |
| D | 2023-02-01 | 2023-01-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +2,886 | 77.7K | +4% | $0 |
| D | 2023-02-01 | 2023-01-30 | NRIX | Ring Christine | GC | S - Sale+OE | $11.78 | -848 | 7,261 | -10% | -$9,989 |
| D | 2023-02-01 | 2023-01-30 | NRIX | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 8,109 | +31% | $0 |
| D | 2023-02-01 | 2023-01-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +3,207 | 24.4K | +15% | $0 |
| D | 2023-02-01 | 2023-01-30 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $11.78 | -1,412 | 23.0K | -6% | -$16.6K |
| D | 2023-02-01 | 2023-01-30 | NRIX | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 4,364 | +28% | $0 |
| D | 2023-02-01 | 2023-01-30 | NRIX | Wolff Stefani | EVP, COO | S - Sale+OE | $11.78 | -424 | 3,940 | -10% | -$4,995 |
| D | 2022-11-01 | 2022-10-30 | NRIX | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 3,752 | +34% | $0 |
| D | 2022-11-01 | 2022-10-31 | NRIX | Wolff Stefani | EVP, COO | S - Sale+OE | $12.88 | -350 | 3,402 | -9% | -$4,508 |
| D | 2022-11-01 | 2022-10-31 | NRIX | van Houte Hans | CFO | S - Sale+OE | $12.88 | -739 | 74.8K | -1.0% | -$9,518 |
| D | 2022-11-01 | 2022-10-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +2,886 | 75.5K | +4% | $0 |
| D | 2022-11-01 | 2022-10-30 | NRIX | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 6,884 | +39% | $0 |
| D | 2022-11-01 | 2022-10-31 | NRIX | Ring Christine | GC | S - Sale+OE | $12.88 | -699 | 6,185 | -10% | -$9,003 |
| D | 2022-11-01 | 2022-10-31 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $12.88 | -1,165 | 21.2K | -5% | -$15.0K |
| D | 2022-11-01 | 2022-10-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +3,207 | 22.4K | +17% | $0 |
| D | 2022-08-02 | 2022-08-01 | NRIX | Wolff Stefani | EVP, COO | S - Sale+OE | $15.67 | -356 | 1,238 | -22% | -$5,579 |
| D | 2022-08-02 | 2022-07-30 | NRIX | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 1,594 | +152% | $0 |
| D | 2022-08-02 | 2022-08-01 | NRIX | van Houte Hans | CFO | S - Sale+OE | $15.67 | -752 | 72.7K | -1% | -$11.8K |
| D | 2022-08-02 | 2022-07-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +2,886 | 73.4K | +4% | $0 |
| D | 2022-08-02 | 2022-07-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +3,207 | 20.4K | +19% | $0 |
| D | 2022-08-02 | 2022-08-01 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $15.67 | -1,186 | 19.2K | -6% | -$18.6K |
| D | 2022-08-02 | 2022-07-30 | NRIX | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 5,327 | +57% | $0 |
| D | 2022-08-02 | 2022-08-01 | NRIX | Ring Christine | GC | S - Sale+OE | $15.67 | -712 | 4,615 | -13% | -$11.2K |
| D | 2022-06-01 | 2022-05-31 | NRIX | van Houte Hans | CFO | M - OptEx | $0.84 | +68.3K | 70.5K | +3,122% | +$57.4K |
| D | 2022-05-03 | 2022-04-30 | NRIX | Wolff Stefani | EVP, COO | M - OptEx | $0.00 | +962 | 962 | New | $0 |
| D | 2022-05-03 | 2022-05-02 | NRIX | Wolff Stefani | EVP, COO | S - Sale+OE | $11.75 | -330 | 632 | -34% | -$3,878 |
| D | 2022-05-03 | 2022-05-02 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $11.75 | -1,098 | 17.2K | -6% | -$12.9K |
| D | 2022-05-03 | 2022-04-30 | NRIX | Hansen Gwenn | CSO | M - OptEx | $0.00 | +3,206 | 18.2K | +21% | $0 |
| D | 2022-05-03 | 2022-04-30 | NRIX | Ring Christine | GC | M - OptEx | $0.00 | +1,924 | 4,063 | +90% | $0 |
| D | 2022-05-03 | 2022-05-02 | NRIX | Ring Christine | GC | S - Sale+OE | $11.75 | -660 | 3,403 | -16% | -$7,755 |
| D | 2022-05-03 | 2022-04-30 | NRIX | van Houte Hans | CFO | M - OptEx | $0.00 | +2,886 | 2,886 | New | $0 |
| D | 2022-05-03 | 2022-05-02 | NRIX | van Houte Hans | CFO | S - Sale+OE | $11.75 | -697 | 2,189 | -24% | -$8,190 |
| D | 2022-01-11 | 2022-01-10 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,486 | +93% | +$2,232 |
| D | 2022-01-11 | 2022-01-10 | NRIX | Ring Christine | GC | S - Sale+OE | $27.14 | -1,200 | 1,286 | -48% | -$32.6K |
| DM | 2022-01-04 | 2022-01-03 | NRIX | Hansen Gwenn | CSO | M - OptEx | $9.06 | +1,828 | 14.6K | +14% | +$16.6K |
| D | 2022-01-04 | 2022-01-03 | NRIX | Hansen Gwenn | CSO | S - Sale+OE | $28.96 | -1,828 | 14.2K | -11% | -$52.9K |
| D | 2021-12-13 | 2021-12-10 | NRIX | Ring Christine | GC | S - Sale+OE | $29.04 | -1,200 | 1,286 | -48% | -$34.8K |
| D | 2021-12-13 | 2021-12-10 | NRIX | Ring Christine | GC | M - OptEx | $1.86 | +1,200 | 2,486 | +93% | +$2,232 |
| D | 2021-12-02 | 2021-12-01 | NRIX | Hansen Gwenn | CSO | M - OptEx | $7.26 | +400 | 14.6K | +3% | +$2,904 |
Purchase Sale Sale after option exercise All abbreviations